Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).
Lepage E, Gisselbrecht C, Haioun C, Sebban C, Tilly H, Bosly A, Morel P, Herbrecht R, Reyes F, Coiffier B. Lepage E, et al. Among authors: sebban c. Ann Oncol. 1993 Sep;4(8):651-6. doi: 10.1093/oxfordjournals.annonc.a058619. Ann Oncol. 1993. PMID: 7694634 Free article. Clinical Trial.
Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte.
Guerci A, Lederlin P, Reyes F, Bordessoule D, Sebban C, Tilly H, Kerneis Y, Biron P, Gisselbrecht C, Herbrecht R, Coiffier B. Guerci A, et al. Among authors: sebban c. Ann Oncol. 1996 Nov;7(9):966-9. doi: 10.1093/oxfordjournals.annonc.a010801. Ann Oncol. 1996. PMID: 9006749 Free article.
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.
Haioun C, Lepage E, Gisselbrecht C, Salles G, Coiffier B, Brice P, Bosly A, Morel P, Nouvel C, Tilly H, Lederlin P, Sebban C, Brière J, Gaulard P, Reyes F. Haioun C, et al. Among authors: sebban c. J Clin Oncol. 2000 Aug;18(16):3025-30. doi: 10.1200/JCO.2000.18.16.3025. J Clin Oncol. 2000. PMID: 10944137 Clinical Trial.
Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.
Bastion Y, Blay JY, Divine M, Brice P, Bordessoule D, Sebban C, Blanc M, Tilly H, Lederlin P, Deconinck E, Salles B, Dumontet C, Brière J, Coiffier B. Bastion Y, et al. Among authors: sebban c. J Clin Oncol. 1997 Aug;15(8):2945-53. doi: 10.1200/JCO.1997.15.8.2945. J Clin Oncol. 1997. PMID: 9256139 Clinical Trial.
Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA).
Mounier N, Haioun C, Cole BF, Gisselbrecht C, Sebban C, Morel P, Marit G, Bouabdallah R, Ravoet C, Salles G, Reyes F, Lepage E. Mounier N, et al. Among authors: sebban c. Blood. 2000 Jun 15;95(12):3687-92. Blood. 2000. PMID: 10845898 Free article. Clinical Trial.
222 results